Medicinal composition for treating cervical cancer, and preparation method, preparation and application of medicinal composition

A cervical cancer and composition technology, applied in the field of medicine, can solve the problems of difficulty in controlling the suitability of drug selection, large side effects, and high risk of drug replacement, etc., and achieve the effect of easy popularization, easy acceptance, and definite curative effect

Inactive Publication Date: 2017-09-29
曾明霞
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are many kinds of drugs for the treatment of cervical cancer, but all of them have relatively large side effects, it is difficult to control the suitability of individual drug selection, and the risk of changing drugs is very high. Therefore, it is necessary to develop a drug that can solve the above problems and meet the treatment needs of patients with cervical cancer. is very necessary

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Take 30g rehmannia glutinosa, 20g raw rehmannia glutinosa, 30g poria cocos, 20g Alisma, 20g cornus, 5g tortoise shell, 10g ligustrum lucidum, 5g digupi, 5g paeonol, 20g medlar, 20g dodder, 8g chuanduan, 20g yam , Scutellaria barbata 20g, Snakegrass chinensis 8g, raw Wulingzhi 5g, raw petunia 5g, raw aconite 5g, and raw syringa radix 5g, respectively pulverized through a 100-mesh sieve, mixed evenly to obtain the target substance for treating cervical cancer pharmaceutical composition.

Embodiment 2

[0022] Take 70g rehmannia glutinosa, 40g raw rehmannia glutinosa, 70g poria cocos, 50g Alisma, 50g cornus, 15g tortoise shell, 30g privet privet, 15g digupi, 15g paeonol, 40g medlar, 40g dodder, 20g chuanduan, 40g yam , Scutellaria barbata 40g, Snakegrass chinensis 20g, raw Wulingzhi 15g, raw black morning glory 15g, raw aconite 15g, raw radix acanthus 15g, respectively pulverized through a 100-mesh sieve, mixed evenly to obtain the target substance for treating cervical cancer pharmaceutical composition.

Embodiment 3

[0024] Take 50g rehmannia glutinosa, 30g raw rehmannia glutinosa, 40g Poria cocos, 30g Alisma, 25g cornus, 10g tortoise shell, 20g Ligustrum lucidum, 15g Digupi, 15g paeonol, 40g medlar, 30g dodder, 10g chuanduan, 30g yam , Scutellaria barbata 40g, Snakegrass chinensis 8g, raw Wulingzhi 5g, raw petunia 5g, raw aconite 5g, and raw radix acanthus 5g, respectively pulverized through a 100-mesh sieve, mixed evenly to obtain the target substance for treating cervical cancer pharmaceutical composition.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating cervical cancer, its preparation method, preparation and application. The pharmaceutical composition for treating cervical cancer comprises raw materials in parts by weight of 30-70 parts of rehmannia glutinosa, 20-40 parts of rehmannia glutinosa, 30-70 parts of Poria cocos, 20-50 parts of Alisma, 20-50 parts of cornus, 50 parts of tortoise shell ~15 parts, 10~30 parts of Ligustrum lucidum, 5~15 parts of Digupi, 5~15 parts of paeonol, 20~40 parts of medlar, 20~40 parts of dodder, 8~20 parts of Chuan Duan, 20~ of Chinese yam 40 parts, 20~40 parts of Scutellaria barbata, 8~20 parts of white snake grass, 5~15 parts of raw Wulingzhi, 5~15 parts of raw black petunia, 5~15 parts of raw aconite, 5 parts of raw Guangmuxiang ~15 servings. The preparation is tablet, powder, capsule, granule and pill prepared by adding pharmaceutically acceptable auxiliary materials to the pharmaceutical composition for treating cervical cancer. The application is the application of the pharmaceutical composition for treating cervical cancer in the preparation of medicines for treating cervical cancer. All medicines of the present invention are combined, act synergistically, and cure cervical cancer mainly.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating cervical cancer, a preparation method, preparation and application thereof. Background technique [0002] Cervical cancer is the most common gynecological malignancy. The high-incidence age of carcinoma in situ is 30-35 years old, and that of invasive carcinoma is 45-55 years old. In recent years, the onset tends to be younger. The widespread application of cervical cytology screening in recent decades has enabled early detection and treatment of cervical cancer and precancerous lesions, and the incidence and mortality of cervical cancer have dropped significantly. Early cervical cancer often has no obvious symptoms and signs, and the cervix may be smooth or difficult to distinguish from cervical columnar heterotopia. Patients with cervical canal are easily missed or misdiagnosed because of the normal appearance of the cerv...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8945A61P35/00A61K35/24A61K35/586
CPCA61K36/36A61K35/24A61K35/586A61K36/076A61K36/185A61K36/285A61K36/39A61K36/40A61K36/43A61K36/539A61K36/638A61K36/65A61K36/71A61K36/748A61K36/804A61K36/815A61K36/884A61K36/8905A61K36/8945
Inventor 曾明霞
Owner 曾明霞
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products